TP53 and leukemia: Moreover, p53-deficient leukemias and lymphomas commonly upregulate p19Arf [20, 47], which can sequester Mdm2, thereby contribute to the massive E177R accumulation, overcome the apoptosis-deficiency and enable tumor cell killing by E177R.